These results, together with the positive, although weak, correlation between TR3 and AR expression levels in prostate tumors and the stimulation of tumorigenesis by TR3 overexpression, suggest that TR3 is a pivotal controller of AR signaling in prostate cancer cells and plays a crucial role in cancer progression and the maintenance of advanced CRPCs. Here, NR4A1 is linked to prostate cancer.